Abstract
A variety of animal models have been used to study the pathogenesis and treatment of pyelonephritis in man. These models have employed a variety of animals such as monkeys, rabbits, guinea pigs, rats, and mice, and have been extensively reviewed by Cotran (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.S. Cotran. Experimental pyelonephritis, in: “The Kidney: Morphology, Biochemistry, Physiology”, C. Roullier, A.F. Muller, ed.Vol. II. Academic Press, New York (1969).
C.P. Adler, H. Ritzman, and H.U. Zollinger, Vergleichende Untersuchungen über die hamatogene und die ascendierende pyelonephritis bei ratten, Virchows Arch [Pathol Anat]: 347: 277 (1969).
A.I. Baude, A. P. Shapiro, and J. Siemienski, Hematogenous pyelonephritis in rats III. Relationship of bacterial species to the pathogenesis of acute pyelonephritis, J. Bacterial. 77: 270 (1959).
R.S. Cotran, E., Vivaldi, D.P., Zangwill, and E. H. Kass, Retrograde Proteus pyelonephritis in rats, Bacteriologie, pathologic, and fluorescent-antibody studies. Am. J. Pathol. 43: 1 (1963).
R.H. Heptinstall. Experimental pyelonephritis. Bacteriological and morphological studies on the ascending route of infection in the rat. Nephron. 1: 73 (1964).
B.W. Hunter, L.L., Souda, and J.P. Sanford. Antibiotic therapy in established chronic experimental Proteus mirabilis pyelonephritis, Antimicrob. Agents Chemother. 3; 608 (1963).
T.E. Miller, and K.B. Robinson. Experimental pyelonephritis: a new method for inducing pyelonephritis in the rat, J. Infect. Dis. 127: 307 (1973).
J.D. Sobel, and D. Kaye. Host factors in the pathogenesis of urinary tract infections. Am. J. Med. 76: 122 (1984).
L. Hagberg, I. Engberg, R. Freter, J. Lam, S. Oiling, and C. Svanborg-Eden., Ascending unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40: 273 (1983).
L.R. Freedman. Experimental pyelonephritis XIII. On the ability of water diuresis to induce susceptibility to E, coli bacteriuria in the normal rat, Yale J. Biol. Med. 39: 255 (1967).
W. Henkel, and R., Commichau. Serumresistenz und nephropathogenitar antigenetisch difinierter Stamme von E. coli III, Experimentelle pyelonephritis mit unterschiedlick serum-resistenten keimen, Z. med. Mikrobiol. Immunol. 156: 297 (1971).
D. Kaye. Antibacterial activity of human urine, J. Clin. Invest. 47: 2374 (1968).
M. Aronson, O. Medalia and B. Griffel. Prevention of ascending pyelonephritis in mice by urease inhibitors. Nephron 12: 94 (1974).
CG. Cobbs, and D., Kaye. Antibacterial mechanisms in the urinary bladder, Yale J. Biol. Med. 40: 93 (1967).
P.B. Beeson, and D. Rowley. The anticomplementary effect of kidney tissue. Its association with ammonia production, J. Exp. Med. 110: 685 (1959).
R.N. Gruneberg, D.A. Leigh, and W. Brumfitt. Escherichiau coli serotypes in urinary tract infection, in: Studies in domiciliary antenatal and hospital practice in urinary tract infections,” F. O’Grady and W. Brumfitt, ed., Oxford University Press, London (1968).
B. Kusecek, H. Wloch, A. Mercer, V. Vaisanen, G. Pluschke, T. Korhonen, and M. Achtman. Lipopolysaccharide, capsule, and fimbriae as virulence factors among 01, 07, 016, 018, 04 075 and Kl, K5, or Kl00 Escherichia coli. Infect. Immun. 43: 368 (1984).
J.F. Van der Bosch, U. Verboom-Sohmer, P. Postma, J. DeGraäff and D. MacLaren, Mannose-sensitive and Mannose-resistant adherence to human uroepithelial cells and urinary virulence of Escherichia coli. Infect. Immun. 29: 226 (1980).
L. Hagberg, U. Jodal, T.K. Korhonen, G. Lidin-Janson, U. Lindberg, and C. Svanborg-Eden. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections, Infect. Immun. 31: 564 (1981).
C. Svanborg-Eden, B. Eriksson, and L.A. Hanson. Adhesion of Escherichia coli to human uroepithelial cells in vitro. Infect. Immun. 18: 767 (1977).
I. Ofek, A. Mosek, and N. Sharon. Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine. Infect. Immun. 34: 708 (1981).
M. Aronson, O. Medalia, L. Schori, D. Mirelman, N. Sharon, and I. Ofek. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl -D-mannopyranoide, J. Infect. Dis. 139: 329 (1979).
L. Hagberg, R. Hull, S. Hull, S. Falkow, R. Freter, and C. Svanborg-Eden. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect. Immun. 40: 265 (1983).
C. Svanborg-Eden, R. Freter, L. Hagberg, R. Hull, S. Hull, H. Leffler, G. SchooInik. Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature (London) 298: 560 (1982).
Varsanen, V., L.G. Tallgren, P.H. Makela, G. Kallenius, H. Hultberg, J. Elo, A. Siitonen, C. Svanborg-Eden, S.B. Svenson, and T. Korhonen, Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet. II: 1366 (1981).
G. Kallenus, R. Mollby, H. Hultberg, S.B. Svenson, B. Cedergren, and J. Winberg, 1981. Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli. Lancet II: 604 (1981).
H. Leffler, and C. Svanborg-Eden. Chemical identification of a glycospingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes, FEMS Microbiol. Lett. 8: 127 (1980).
C. Svanborg-Eden, L.M. Bjursten, R. Hull, S. Hull, K.E. Magnussen, Z. Moldovano, and H. Leffler. Influence of adhesin on the interaction of Escherichia coli with human phagocytes. Infect. Immun. 44: 672 (1984).
U.L. Lindberg, A. Hanson, U. Jodal, G. Lidin-Janson, K. Lincoln, and S. Oiling. Asymptomatic bacteriurea in school girls, II. Differences in Escherichia coli causing asymptomatic bacteriuria, Acta. Paediatr. Scand. 64: 432 (1975).
S. Oiling, L.A. Hanson, J. Holmgen, U. Jodel, K. Lincoln and U. Lindberg. The bactericidal effect of normal human serum on E, coli strains from animals and from patients with urinary tract infections, Infection 1: 24 (1973).
A. Glynn, A. Brumfitt, and C.J. Howard. Kantigens of Escherichia coli and renal involvement in urinary tract infections. Lancet 1: 514 (1971).
J.W. Smith, and B. Kaijser. The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis, J. Clin. Invest. 58: 276 (1976).
B. Herrmann, and L.G. Burman. Chemoattracting effect of human urine on motile Escherichia coli, FEMS Microbiol. Lett. 20: 411 (1983).
G.M. Kalmanson, M. Turck, H.J. Harwick, and L.B. Guze. Urinary tract infection: Localization and virulence of Escherichia coli, Lancet 1: 134 (1975).
D. Low, V. David, D. Lark, G. Schoolnik, and S. Falkow. Gene cluster governing the production of hemolysin and mannose-resistant hemaglutination are closely linked in Escherichia coli serotype 04 and 06 isolates from urinary tract infections, Infect. Immun. 43: 353 (1984).
R.M. Al-Ssum, and D.M. Harris. The contribution of diffusable toxins of Pseudomonas aeruginosa to the pathogenesis of experimental pyelonephritis, J. Infect. 4: 49 (1982).
B. Kaijser, P. Larsson, and S. Oiling. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity, Infect. Immun. 20: 78 (1978).
J.P. Sanford, B.W. Hunter, and L.L. Souda. The role of immunity in the pathogenesis of experimental hematogenous pyelonephritis, J. Exp. Med. 115: 383 (1962)
B. Kaijser. Immunology of Escherichia coli: K antigen and its relation to urinary tract infection, J. Infect. Dis. 127: 670 (1973).
I. Mattsby-Baltzer, L.A. Hanson, S. Oiling, and B. Kaijser. Experimental Escherichia coli ascending pyelonephritis in rats: Active peroral immunization with live Escherichia coli. Infect. Immun. 35: 647 (1982).
F.H. Millazo, and G.J. Delisle. Immunoglobulin A proteases in gram-negative bacteria isolated from human urinary tract infections. Infect. Immun. 43: 11 (1984).
C. Svanborg-Eden, D. Briles, L. Hagberg, J. McGhee, and S. Michalec. Genetic factors in host resistance to urinary tract infection. Infection 12: 118 (1984).
H. Pitchon, R. Glassock, G.M. Kalmanson, and L.B. Guze. Experimental pyelonephritis: The effect of T-cell deficiency in the course of hematogenous enterococcal pyelonephritis in the mouse. Am. J. Pathol. 115: 25 (1984).
C. Svanborg-Eden, B. Andersson, L. Hagberg, L.A. Hanson, H. Lemberg, H. Leffler, G. Magnussen, G. Noori, J. Dahmen, and T. Sonderstrom. Receptor analogues and anti-pili antibodies as inhibitors of bacterial attachment in vivo and vitro, Proc. N.Y. Acad. Sei. 409: 580 (1983).
T. Nishi, and K. Tsuchiya. Experimental urinary tract infection with Pseudomnonas aeruginosa in mice. Infect. Immun. 22: 508 (1978).
W.P. Keane, and L.R. Freedman. Experimental pyelonephritis XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis, Yale J. Biol. Med. 40: 231 (1967).
L.B. Guze, F. Silverblatt, J.Z. Montogomerie, K. Ishida, and G.M. Kalmanson. Lack of significance of pili in ascending Escherichia coli pyelonephritis, Scand. J. Infec. Dis. 15: 57 (1983).
E.G. Hubert, G.M. Kalmanson and L.B. Guze. Antibiotic therapy of Escherichia coli pyelonephritis produced in mice undergoing chronic diuresis, Antimicrob. Agents. Chemother. 8: 507 (1968).
M. Rocha, and F.R. Fekety. Acute inflammation in the renal cortex and medulla following thermal injury, J. Exp. Med. 119: 131 (1964).
E.H. Thiele. An in vivo pyelonephritis assay for screening therapeutic agents, J. Antibiot. 27: 31 (1984).
O. Zak, F. Kradolfer, E.A. Konopka, S. Kunz and E. Batt. CGP7174/E (Takeda SCE 129), Activity against systemic and urinary tract infections in mice and rats, in “Current Chemotherapy”, Vol 2. Proceedings of the 19th International Congress of Chemotherapy, Zurich, ASM, Washington, D.C. 846 (1978).
A.Q. Thomson, and E.F. Fowler, Carrageenan: A review of its effects on the immune system. Agents and Actions 11 (3): 265 (1981).
E.F. Fowler, J.G. Simpson and A.W. Thomson. Histological and ultrastructural changes following carageenan injection in the mouse, J. Path. 132: 63 (1980).
R. MoeHering. Enterococcal infections in patients treated with moxalactam. Rev. Infect. Dis. 4: S708 (1982).
J. Fletcher, and E. Goldstein. The effect of parenteral iron preparations on experimental pyelonephritis, Br. J. Exp. Pathol. 51: 280 (1970).
K.R. Comber. Pathogenesis of an experimental pyelonephritis model in the mouse and its use in the evaluation of antibiotics, in: “Chemotherapy”, Vol 2, J.D., Williams and A.M. Gedes, ed.. Plenum Publishing Corp., New York (1976).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Fernandes, P.B., Shipkowitz, N.L., Bower, R.R. (1987). Murine Models for Studying the Pathogenesis and Treatment of Pyelonephritis. In: Bondi, A., Stieritz, D.D., Campos, J.M., Miller, L.A. (eds) Urogenital Infections. Advances in Experimental Medicine and Biology, vol 224. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8932-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8932-3_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8934-7
Online ISBN: 978-1-4684-8932-3
eBook Packages: Springer Book Archive